Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Safety and Effectiveness of Brigatinib in Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non-Small Cell Lung Cancer (NSCLC) in Argentina: A Post-Marketing Surveillance Study.
Journal: Drugs - real world outcomes
Published: January 30, 2025
Early Onset Pulmonary Events and Management Strategies during the Treatment of ALK Positive NSCLC Patients with Brigatinib
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: May 15, 2023
Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC.
Journal: Thoracic cancer
Published: March 27, 2023
Personalized medicine: paradigm shift in ALK positive non-small cell lung cancer: a case report.
Journal: Journal of medical case reports
Published: February 28, 2023
Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practice.
Journal: Journal of thoracic disease
Published: May 21, 2022
Treatment of ALK Positive Non-small Cell Lung Cancer with Alectinib: A Case Report and Literature Review
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: September 15, 2021
An overview of alectinib hydrochloride as a treatment option for ALK positive non-small cell lung cancer.
Journal: Expert opinion on pharmacotherapy
Published: July 06, 2021
Design, synthesis and application of near-infrared fluorescence probe IR-780-Crizotinib in detection of ALK positive tumors.
Journal: Protein expression and purification
Published: March 13, 2021
Access to Tyrosine Kinase Inhibitors and Survival in Patients with Advanced EGFR+ and ALK+ Positive Non-small-cell Lung Cancer Treated in the Real-World.
Journal: Clinical lung cancer
Published: November 04, 2020
Alectinib Treatment of ALK Positive Non Small Cell Lung Cancer Patients with Brain Metastases: Our Clinical Experience.
Journal: Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)
Published: October 04, 2020
Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance.
Journal: European journal of medicinal chemistry
Published: December 17, 2019
Last Updated: 10/31/2025